Cambridge, MA, United States of America

Michael Schebesta

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Obsidian Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Schebesta. Retrieved from https://idiyas.com/inventor/michael-schebesta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Schebesta: Innovator in Biocircuit Systems

Introduction

Michael Schebesta is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of regulatable biocircuit systems. His innovative work supports the discovery and development of therapeutic modalities.

Latest Patents

Michael holds a patent for "CA2 compositions and methods for tunable regulation." This patent provides modular and tunable protein expression systems, which are essential for advancing therapeutic applications. His work in this area demonstrates a commitment to enhancing biotechnological solutions.

Career Highlights

Michael Schebesta is currently associated with Obsidian Therapeutics, Inc., where he continues to push the boundaries of biocircuit technology. His expertise in protein expression systems has positioned him as a key player in the biotechnology sector.

Collaborations

Throughout his career, Michael has collaborated with talented individuals such as Michelle Lynn Ols and Dhruv Kam Sethi. These partnerships have fostered innovation and contributed to the success of various projects.

Conclusion

Michael Schebesta's work in biocircuit systems exemplifies the intersection of innovation and biotechnology. His contributions are paving the way for future advancements in therapeutic modalities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…